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In humans, skin is the major source for vitamin D and
interestingly its production in response to UVB is conserved
through evolution. The role of UVB-induced vitamin D pro-
duction, which has been demonstrated in earlier life forms
such as plants and phytoplankton, is unclear. In view of the
data presented here, an important physiologic function for
vitamin D in regulating components of the innate immune
system is emerging.
Thus, taken together, these findings suggest the evolu-
tion of an intriguing biosystem wherein the skin interacts
with the environment to enhance its antimicrobial protection
and repair.
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Neonatal Ultraviolet Radiation Exposure Is Critical for Malignant
Melanoma Induction in Pigmented Tpras Transgenic Mice
To the Editor:
Malignant melanoma (MM) in humans develops within a
complex etiologic framework of genetic, host, and environ-
mental factors (Goldstein and Tucker, 2001). The strongest
environmental risk factor is sun exposure (Sulaimon et al,
2003). In the mouse, wild-type animals are resistant to MM
development even when exposed to repeated treatments
with ultraviolet radiation (UVR) (Gallagher et al, 1984). Chronic
UVR treatment regimens, however, have increased MM
penetrance by up to 26% in mice carrying various trans-
genes capable of inducing spontaneous MM development,
or melanocytic hyperplasia, e.g., Tyr-SV40Tag (Klein-Szanto
et al, 1994; Kelsall and Mintz, 1998), TPras (Broome Powell
et al, 1999) and Mt-Hgf/Sf (Noonan et al, 2000) mice. More
recently, Noonan et al (2001) showed that a single neonatal
dose of 9 kJ per m2 was far more effective than chronic
treatments at inducing MM in the Mt-Hgf/Sf transgenics.
Kannan et al (2003) used the neonatal UVR regimen on mice
with melanocyte-specific activation of Hras on a background
of either Ink4a or Arf nullizygosity. At 22 wk, Ink4a/:Tyr-Hras
and Arf/:Tyr-Hras animals developed spontaneous MM,
with an incidence of 35% and 53%, respectively (Chin et al,
1997). Importantly, neonatal UVR exposure resulted in a
marked increase in MM development only in the Arf/:Tyr-
Hras animals (penetrance rose to 88%) (Kannan et al, 2003),
implying that a defect in the p53 pathway may be necessary
for UVR-induced MM. Arf/:Tyr-Hras tumors were charac-
terized by Cdk6 amplification and Ink4a mutation, genetic
lesions that were never observed in non-UVR-induced MM.
Notably, these secondary mutations indicate that these UVR-
induced MMmay only arise on an activated Hras background
when both the p53 and pRb pathways are compromised.
It has previously been demonstrated that pigmented Tyr-
SV40Tag mice treated with repeated neonatal UVR doses
from days 3–10, show increased rates of MM compared to
untreated animals (Klein-Szanto et al, 1994; Kelsall and
Mintz, 1998). These mice did not, however, develop me-
lanomas over their limited lifespan when treated with a sin-
gle neonatal dose. All subsequent studies have used albino
mouse strains for neonatal UVR experiments.
Evidence suggests that the Ras pathway is pivotal for
MM development. The RAS family is comprised of NRAS,
HRAS, KRAS, which are all involved in the mitogen-activat-
ed protein kinase (MAPK) and phosphatidylinositol 3-kinase
(PI3K) signalling cascades (Busca et al, 2000). There is a
high frequency of BRAF and NRAS mutation in melanocytic
Abbreviations: MAPK, mitogen-activated protein kinase; MM,
malignant melanoma; PI3K, phosphatidylinositol 3-kinase; UVR,
ultraviolet radiation
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nevi and MM (e.g., Davies et al, 2002; Pollock et al, 2003
and reviewed in Rodolfo et al, 2004; de Snoo and Hayward,
2005). Human cutaneous MM from chronically sun-exposed
body sites commonly harbor NRAS mutations, thus sup-
porting a possible role for solar UVR in their genesis (van
Elsas et al, 1996; Jiveskog et al, 1998). As discussed above,
activated Hras has been shown to be a potent amplifier of
tumorigenesis in genetically modified mice carrying dele-
tions of the Ink4a or Arf genes, however, to date there have
been no reports assessing the capability of Hras alone to
induce MM in mice treated with a neonatal dose of UVR. We
thus treated brown mice (mixed C3H/Sv129 strain back-
ground) carrying a melanocyte-specific mutant Hras (G12V)
transgene (TPras) (Powell et al, 1995), with a similar neo-
natal UVR regimen to that used by Noonan et al (2001). We
used an apparatus that holds three Phillips FS40 UVB lamps
mounted 34 cm above the mice (Phillips, Andover, MA).
Pups (2–3 d old) were exposed for 16 min, to give a total
dose of 8.15 kJ m2 (UVA 320–400 nm, 2.36 kJ m2 UVB
280–320 nm, 5.77 kJ m2, UVC 250–280, 0.02 kJ m2), a
slightly lower dose than previously used (Noonan et al,
2001). All experiments were undertaken after receiving in-
stitutional approval. The UVR cohort (n¼ 14) developed
in situ cutaneous MM with a penetrance of 57% by 12 mo,
whereas none of the untreated cohort (n¼42) developed
tumors (Fig 1). This is markedly higher penetrance and ear-
lier average age of onset than that of the similarly treated
Mt-Hgf/Sf transgenics (Noonan et al, 2001; Recio et al,
Figure 1
Melanoma penetrance in ultaviolet radiation (UVR)-treated TPras
mice. A single UVR dose of 8.15 kJ m2 to neonatal skin cooperates
with melanocyte-specific activated Hras (n¼ 14, dashed line) to facil-
itate malignant melanoma (MM) formation. Untreated animals (n¼42)
are represented by a solid line. Animals that died without developing
MM are represented by a cross (UVR treated) or a dash (untreated).
There is a significant difference (po0.001, log rank test) in MM inci-
dence between the treated and untreated groups.
Figure 2
Morphology and histopathology of melanomas from ultravioler radiation (UVR)-treated TPras mice. (a) Hematoxylin and eosin (H&E) skin
section from an untreated adult TPras mouse. Note the scattered melanin deposits throughout the dermis and large, dense melanin deposits in the
deep dermis above the muscle layer, see arrow (b) H&E skin section from an untreated neonatal TPras mouse (2 d old). Note the lack of visible
melanin. Brightfield images of untreated (2-d-old) mouse skin sections (c) wild-type and (d) Tpras, stained for Tyrp1 (red) and counter-stained with
Mayers’ haematoxylin (blue). The majority of wild-type melanocytes are located within the hair follicles, see arrow. In contrast, TPras melanocytes
are more frequency observed in the extra-follicular dermis, see arrow. (e) Cutaneous melanoma arising on the dorsal skin surface. Scale bar
increments are of 1 mm. (f–h) H&E sections of a melanoma from an UVR-treated TPrasmouse. Note the dermal origin of the lesion (f), hyperplasia of
the epidermis and lack of epidermal junctional involvement, see arrow (g), atypical highly pigmented melanocytes within the tumor, see arrow (h). In
all cases except (e), scale bar¼50 mm.
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2002). Previous experiments in which our pigmented TPras
animals were exposed to a chronic UVR regimen (5.6–8.06
kJ m2 biweekly for 38 wks) did not induce MM (Broome
Powell et al, 1999). To assess the reasons for the differences
in UVR-induced MM susceptibility observed, we examined
skin sections from adult TPras and neonatal TPras and wild
type littermates. Adult TPras skin was highly pigmented,
with scattered melanin in the upper dermis and large ag-
gregates in the deep dermis (Fig 2a). In contrast, 2-d-old
TPras skin lacked visible melanin (Fig 2b). The majority of
melanocytes in neonatal skin of wild-type mice were
located within hair follicles (Fig 2c), whereas there were
noticeably more melanocytes in the extra-follicular dermis
of TPras mice (Fig 2d).
UVR-induced MM ranged in size from 0.4–1.2 cm2
and were heavily pigmented (Fig 2e). These lesions appear
to originate in the dermis (Fig 2f), lack the classical junc-
tional changes observed in human MM (Fig 2g), and contain
large atypical melanocytes (Fig 2h). The dermal origin of
these lesions reflects the location of the hyperplastic me-
lanocytes in the adult animals (i.e., not along the basal layer
as in humans) (Powell et al, 1995). Hyperplasia of the ep-
idermis was frequently observed in UVR-treated mouse skin
(Fig 2g).
The mutation status of the Cdkn2a locus in these tumors
was determined by immunohistochemistry (IHC) and anal-
ysis of tumor DNA and RNA (Fig 3 and Table I). No genomic
deletion was observed and both transcripts were expressed
in two of three tumors examined. Ink4a was detected in five
of seven MM by IHC. The melanoma cell-line derived from
one of the tumors lost Ink4a as it was passaged.
This study confirms the importance of a single neona-
tal UVR dose, compared with chronic UVR regimens in
adult mice, for MM induction. The reason neonatal me-
lanocytes are more susceptible to transformation than adult
Figure 3
Molecular status of Cdkn2a locus in melanomas from ultraviolet ra-
diation (UVR)-treated TPrasmice. Products from semi-quantitative PCR
analysis electrophoresed in ethidium bromide-stained agarose gels. Pan-
els (a) and (b) show results of genomic PCR to assess relative copy
number of the Ink4a and Arf genes, respectively. The three lanes on the left
contain DNA isolated from a melanoma cell line (derived from tumor ma-
lignant melanoma (MM)-1), at passage 4, 7, and 19, respectively. Ink4a is
initially present but subsequently lost as the culture is passaged. Exon 1b
(Arf) was already lost at passage 4, indicating that is was deleted prior to
exon 1a (Ink4a). At each of these passages, all cells were of melanocytic
origin as assessed by morphology and pigmentation. Lanes MM-1 and
MM-2 represent two melanomas. Liver and water were used as controls.
All TPras MM DNAs showed similar copy number of both exon1a (Ink4a,
300 bp) and exon1b (Arf, 283 bp) as judged by their ratios to Gapdh (220
bp). (c) Brightfield image of MM-3 showing strong nuclear staining for
Ink4a (red) in the majority of tumor cells, using SC-1207 rabbit polyclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, California) diluted 1:300,
counterstained with Mayers’ hematoxylin (blue) (scale bar¼ 50 mm).
Table I. Molecular status of Cdkn2a locus in melanomas from UVR-treated Tpras mice
Sample ID
Genomic PCR qRT-PCR IHC Percent stromal
1a exon 1b exon 2 exon 3 exon Arf Ink4a Ink4a A
MM-1 a a a a o0.5-fold o0.5-fold ND 10–20
MM-2 a a a a 42.0-fold 42.0-fold þ 5–15
MM-3 b b b b 42.0-fold 42.0-fold þ 20–30
MM-4 b b b b b b þ þ þ 20–30
MM-5 b b b b b b ND 10–20
MM-6 b b b b b b þ 10–20
MM-7 b b b b b b þ 5–15
Line A a –c a a o0.5-foldd o0.5-foldd NA
DNA and RNA were extracted using DNeasy and RNeasy Qiagen kits. respectively. Cdkn2a copy number was assessed by multiplex semi-quantitative
PCR with exon-specific primers using Gapdh as control (primers available on request). Expression levels of Ink4a and Arf were determined by Quantitect
SYBR Green (Qiagen, Qiagen, Germany) real-time PCR, using a Rotorgene 3000 cycler (Corbett Research, Australia). Data were analyzed using
Rotorgene 6 software (Corbett Research) with the Pfaffl equation method (Pfaffl, 2001). b-Actin was used as a PCR control, and MM were compared to
wild-type skin expression, with the relative expression level assessed to be upregulated (42.0-fold); roughly equal (within 0.5–2.0-fold); or downreg-
ulated (o0.5-fold). Lesions MM-4 and MM-5 originated in the same animal. Immunohistochemistry (IHC) for Ink4a was performed as described in Fig 3.
aPCR product observed.
bNot done due to lack of availability of RNA or DNA.
cPassage 4.
dPassage 7.
UVR, ultraviolet radiation; Line A, cell line derived from MM-1; –, no PCR product observed; ND, not detected; þ , positive;þ þ þ , strongly positive;
NA, not applicable; MM, malignant melanoma.
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melanocytes is unclear, but it may be that they are imma-
ture and not fully differentiated, and/or, some are still located
in the epidermis in newborn skin whereas in adult dorsal skin
they are invariably located in the dermis (reviewed in Hirobe,
1995).
In conclusion, our work has demonstrated that neonatal
UVR treatments are probably as effective at inducing MM in
pigmented mice as albino strains. Furthermore, we have
shown that RAS activation alone is sufficient to predispose
melanocytes to UVR-induced transformation, and, although
the precise mechanism is yet to be determined, it does
not always involve loss of Ink4a or Arf. It may be that ac-
tivated Ras simply promotes melanocyte proliferation, or al-
ternatively, that it may interfere with the DNA damage
response and apoptotic pathways. This mouse model fur-
ther consolidates the mounting evidence that NRAS or BRAF
mutations co-operate with solar UVR in the development of
melanoma.
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A Missense Mutation in the Cadherin Interaction Site of The
Desmoglein 4 Gene Underlies Localized Autosomal
Recessive Hypotrichosis
To the Editor:
We recently described a novel form of hair loss, termed
localized autosomal recessive hypotrichosis (LAH, OMIM
607903), which is a rare, autosomal recessive disorder af-
fecting the scalp, trunk and extremities, and largely sparing
the facial, pubic and axillary hair (Kljuic et al, 2003). Typical
hairs are fragile and break easily, leaving short sparse scalp
hairs with a characteristic appearance. We and others re-
ported linkage of LAH to chromosome 18, in the region of
the desmosomal cadherin gene cluster (Kljuic et al, 2003;
Rafiq et al, 2003), in which we discovered a novel member
of this gene family, known as desmoglein 4 (Kljuic et al,
2003). We first identified a large, intragenic deletion of exons
5–8 in the desmoglein 4 gene as the underlying mutation in
two unrelated families of Pakistani origin (Kljuic et al, 2003),
which was then subsequently reported in a total of five ad-
ditional Pakistani families by our group (Moss et al, 2004)
Abbreviations: DSG4/DSG4, human desmoglein 4 gene/protein;
LAH, localized autosomal recessive hypotrichosis
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